Real-world comparison of monotherapy and concomitant medication use with biologic therapies for psoriasis: Ixekizumab versus guselkumab

被引：0
|
作者：
Blauvelt, Andrew [1 ]
Burge, Russel [2 ]
Charbonneau, Bridget [2 ]
Malatestinic, William [2 ]
Zhu, Baojin [2 ]
Wang, Fangyu [2 ]
Lockshin, Benjamin [3 ]
机构：
[1] Oregon Med Res Ctr, Portland, OR USA
[2] Eli Lilly & Co, Indianapolis, IN 46285 USA
[3] DermAssociates, Rockville, MD USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2021年 / 85卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
26648
引用
收藏
页码：AB23 / AB23
页数：1
相关论文
共 50 条
  • [1] Real-world drug survival of guselkumab, ixekizumab and secukinumab for psoriasis
    Iznardo, H.
    Vilarrasa, E.
    Lopez-Ferrer, A.
    Puig, L.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : 660 - 662
  • [2] Real world use of ixekizumab is associated with reductions in concomitant medications among biologic-experienced or biologic-naive patients with psoriasis
    Wu, Jashin J.
    Zhu, Baojin
    Burge, Russel
    Goldblum, Orin
    Choong, Casey
    Edson-Heredia, Emily
    Amato, David
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB114 - AB114
  • [3] Real-world drug survival of ixekizumab for psoriasis
    Lee, Erica B.
    Pithadia, Deeti J.
    Reynolds, Kelly A.
    Reddy, Shivani P.
    Egeberg, Alexander
    Wu, Jashin J.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (01) : 270 - 272
  • [4] Impact of previous biologic use and body weight on the effectiveness of guselkumab in moderate-to-severe plaque psoriasis: a real-world practice
    Hung, Yi-Teng
    Lin, Yu-, Jr.
    Chiu, Hsien-Yi
    Huang, Yu-Huei
    [J]. THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2021, 12
  • [5] A Real World Comparison of Methods for Assessing Dosing Patterns of Biologic Therapies for Psoriasis
    Iskandar, Ireny Y. K.
    Warren, Richard B.
    Evans, Ian
    McElhone, Kathleen
    Owen, Caroline M.
    Burden, A. David
    Smith, Catherine H.
    Reynolds, Nick J.
    Griffiths, Christopher E. M.
    Ashcroft, Darren M.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 273 - 274
  • [6] Comparison of real-world treatment patterns among patients with psoriasis prescribed ixekizumab or secukinumab
    Blauvelt, Andrew
    Shi, Nianwen
    Burge, Russel
    Malatestinic, William N.
    Lin, Chen-Yen
    Lew, Carolyn R.
    Zimmerman, Nicole M.
    Goldblum, Orin M.
    Zhu, Baojin
    Murage, Mwangi J.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 82 (04) : 927 - 935
  • [7] Comparison of Real-World Treatment Patterns Among Psoriasis Patients Treated with Ixekizumab or Adalimumab
    Blauvelt, Andrew
    Shi, Nianwen
    Burge, Russel
    Malatestinic, William N.
    Lin, Chen-Yen
    Lew, Carolyn R.
    Zimmerman, Nicole M.
    Goldblum, Orin M.
    Zhu, Baojin
    Murage, Mwangi J.
    [J]. PATIENT PREFERENCE AND ADHERENCE, 2020, 14 : 517 - 527
  • [8] Comparison of Real-World Treatment Patterns Among Biologic-Experienced Patients with Psoriasis Treated with Ixekizumab or Secukinumab Over 18 Months
    Andrew Blauvelt
    Nianwen Shi
    Russel Burge
    Najwa Somani
    Terri L. Ridenour
    Baojin Zhu
    Bilal Atiya
    Carolyn R. Lew
    Nicole M. Zimmerman
    Mwangi J. Murage
    [J]. Dermatology and Therapy, 2021, 11 : 2133 - 2145
  • [9] Anti-IL23 biologic therapies in the treatment of psoriasis: real-world experience versus clinical trials data
    Angelo Ruggiero
    Matteo Megna
    Gabriella Fabbrocini
    Sonia Sofia Ocampo-Garza
    [J]. Immunologic Research, 2023, 71 : 328 - 355
  • [10] Anti-IL23 biologic therapies in the treatment of psoriasis: real-world experience versus clinical trials data
    Ruggiero, Angelo
    Megna, Matteo
    Fabbrocini, Gabriella
    Ocampo-Garza, Sonia Sofia
    [J]. IMMUNOLOGIC RESEARCH, 2023, 71 (03) : 328 - 355
12345